Population
Patients presenting for cardiac surgery, including those undergoing cardiopulmonary bypass or off-pump…
Design
Review
Authors
Loading...
Antithrombin III use in cardiac surgery remains unproven; leaves open its role in thrombin control and bleeding reduction.
A review of hemostatic balance in cardiac surgery patients, highlighting the potential of antithrombin III to better control thrombin generation during cardiopulmonary bypass and reduce postoperative bleeding.
Weisinger et al. (1998) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: